Literature DB >> 16951911

Osteoporosis in men: are we referring enough for DXA and how?

Haider Al Attia1, Bruce Adams.   

Abstract

The aim of the study is to determine the pattern of male referrals to an osteodensitometry unit in a tertiary hospital in UAE. In this study, we reviewed the records of male patients referred for dual X-ray absorptiometry over 9 months since the establishment of the unit. Indications for scanning were categorized into high and medium risk and infrequent causes of osteopenia/osteoporosis. They were ranked according to frequency. The outcome was documented by category and patients were considered normal when they have bone mineral densities (BMD) over 0.82 g/cm(2), osteopenia between 0.60 and 0.82 g/cm(2), and osteoporosis below 0.60 g/cm(2) for hips and lumbar spine. The site with the lowest value was taken as representative of the patient's BMD status. The ages of the patients ranged from 16 to 91 years (mean of 55.2 years). Male referrals made up 8.8% (71/805) over the 9-month period. The number of indications was 83 accounting for 1.16 per patient. Most common reasons were patients on corticosteroid therapy (20.5%), bone rarefaction on radiographs (13%), and fragility fractures (12%). Others included back pain, general aches and pains, querying osteoporosis, and miscellaneous causes that made up 8.5% each. These were followed by immobilization, (6%) arthropathies (6%), excess alcohol intake (3.5%), aging, (2.5%), and hepatorenal disorders (2.5%). A positive family history of osteoporosis, treatment for neoplasia, smoking, and chronic obstructive airway disease (1% each) were the least common reasons for referral. Thirty-five patients (49%) had osteopenia, 16 (22.5%) had osteoporosis, and 20 (28%) were normal. The low referral rate and relatively high normal outcome among men suggest that osteoporosis is still viewed as a disease of females. This aberrant referral pattern, when viewing the majority of indications, reflects an inability to prioritize the reasons for referral. It is prudent, therefore, to instill an awareness of the increasing importance of osteoporosis in men in the minds of the referring clinicians.

Entities:  

Mesh:

Year:  2006        PMID: 16951911     DOI: 10.1007/s10067-006-0406-z

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  9 in total

Review 1.  Osteoporosis in men.

Authors:  J P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

2.  Elderly African-American and Caucasian men are infrequently screened for osteoporosis.

Authors:  J Steuart Richards; Heather A Young; Robert DeSagun; Gail S Kerr
Journal:  J Natl Med Assoc       Date:  2005-05       Impact factor: 1.798

3.  Prevalence of low femoral bone density in older U.S. adults from NHANES III.

Authors:  A C Looker; E S Orwoll; C C Johnston; R L Lindsay; H W Wahner; W L Dunn; M S Calvo; T B Harris; S P Heyse
Journal:  J Bone Miner Res       Date:  1997-11       Impact factor: 6.741

Review 4.  Unresolved issues in osteoporosis in men.

Authors:  E Seeman
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 5.  Osteoporosis in men.

Authors:  S Amin; D T Felson
Journal:  Rheum Dis Clin North Am       Date:  2001-02       Impact factor: 2.670

Review 6.  Osteoporosis in men.

Authors:  Jant M Campion; Michael J Maricic
Journal:  Am Fam Physician       Date:  2003-04-01       Impact factor: 3.292

Review 7.  Osteoporosis in men.

Authors:  F H Anderson
Journal:  Int J Clin Pract       Date:  1998 Apr-May       Impact factor: 2.503

8.  Hip fractures in the elderly: a world-wide projection.

Authors:  C Cooper; G Campion; L J Melton
Journal:  Osteoporos Int       Date:  1992-11       Impact factor: 4.507

Review 9.  Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management.

Authors:  P R Ebeling
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 4.271

  9 in total
  5 in total

1.  Testing and treatment for osteoporosis following hip fracture in an integrated U.S. healthcare delivery system.

Authors:  A Shibli-Rahhal; M S Vaughan-Sarrazin; K Richardson; P Cram
Journal:  Osteoporos Int       Date:  2011-01-27       Impact factor: 4.507

2.  Lack of biochemical hypogonadism in elderly Arab males with low bone mineral density disease.

Authors:  Haider M Al Attia; Krishnasamy Jaysundaram; Fouad Saraj
Journal:  Rheumatol Int       Date:  2009-06-12       Impact factor: 2.631

3.  Approach in glucocorticoid-induced osteoporosis prevention: results from the Italian multicenter observational EGEO study.

Authors:  U Massafra; S Migliaccio; C Bancheri; F Chiacchiararelli; F Fantini; F Leoni; L S Martin; A Migliore; B Muccifora; C Napolitano; R Pastore; A Ragno; S Ronzoni; M Rotondi; M Tibaldi; P Villa; V Vinicola; E D'Erasmo; P Falaschi; G Minisola
Journal:  J Endocrinol Invest       Date:  2012-03-06       Impact factor: 4.256

4.  Selecting men for bone densitometry: performance of osteoporosis risk assessment tools in Portuguese men.

Authors:  P Machado; M Coutinho; J A P da Silva
Journal:  Osteoporos Int       Date:  2009-09-02       Impact factor: 4.507

Review 5.  Bone health nutrition issues in aging.

Authors:  Karen Plawecki; Karen Chapman-Novakofski
Journal:  Nutrients       Date:  2010-11-08       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.